openPR Logo
Press release

Congestive Heart Failure (CHF) Treatment Devices Market Latest Trends by 2024

04-10-2018 03:52 PM CET | Health & Medicine

Press release from: Persistence Market Research

Congestive Heart Failure (CHF) Treatment Devices Market Latest

Congestive Heart Failure (CHF) is a chronic condition of a body, which adversely affects the pumping efficiency of the cardiac muscles and the heart. It occurs due to accretion of fluid around the heart that may contribute towards ineffective pumping of the heart. This condition may result in shortness of breathing, swelling and weakness. Left-sided CHF is the more commonly noted than right-sided CHF. Left-sided CHF occurs due to malfunctioning of the left ventricle leading to fluid accumulation in lungs making breathing difficult. In right-sided CHF, blood backs up in blood vessels leading to fluid retention in lower extremities of the body including abdomen and other vital organs. Common reasons for onset of congestive heart failure are hypertension, coronary arterial disease and malfunctioning of heart valves. Some symptoms for onset of CHF include continued fatigue, irregular heartbeat, chest pain, increased need to urinate, wheezing, continued weight gain and fainting. Symptoms vary with the severity of the disease. It can be diagnosed by a careful physical examination and selected laboratory tests. Some of these are EEG, ECG, MRI, various stress tests, blood tests and cardiac catherization.

Request Report for Table of Contents @ https://www.persistencemarketresearch.com/toc/12643

Lifestyle modification, administration of prescription medicines, mechanical therapies and surgical intervention are four widely adopted treatments for CHF. Mechanical therapies and surgical interventions are more commonly adopted treatments by physicians in hospitalization cases. The devices used for the treatment of congestive heart failure include implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy (CRT), ventricular assist devices (VADs), or pacemakers.

Increasing prevalence of cardiovascular diseases across regions is one the major factors driving the revenue growth of congestive heart failure treatment devices globally. Lifestyle related factors are expected to add to growing disease incidence of CVDs and thus raise adoption of treatments. Fast track approvals of devices coupled with technological advancement in developed countries will propel market revenues further. Huge unmet treatment demand for congestive heart failure is expected to be noted in developing markets. High cost of devices and unfavorable reimbursement policies are few factors that could hinder the revenues growth of the congestive heart failure treatment market.

The congestive heart failure treatment devices are expected show significant growth in demand over the forecast period owing to rising incidences of cardiovascular diseases. Congestive heart failure is one of the most common medical conditions which is responsible for the death of people globally. Around 6.5 million of people are diagnosed with congestive heart failure every year. According to a survey around 2% of global population are hospitalized due to congestive heart failure.

Based on product type, congestive heart failure treatment devices are segmented as cardioverter defibrillators (ICD), cardiac resynchronization therapy (CRT), ventricular assist devices (VADs) and pacemakers. The Implantable Cardioverter Defibrillators (ICDs) is expected to hold the maximum share of congestive heart failure devices market. The ventricular assist devices (VADs) segment is expected to show significant growth over the forecast period due to technological advancement.


Based on the end user, the congestive heart failure treatment devices market is segmented as hospitals, cardiovascular center, and ambulatory surgical center. The hospital is expected to share maximum share of congestive heart failure devices market among all end user.

Based on geography, global congestive heart failure devices market is segmented into five broad regions viz. North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America is expected to be the largest market for congestive heart failure devices market. This market is then followed by Europe and Asia-Pacific region. North America and Europe market are growing significantly owing to the high prevalence of cardiovascular diseases. Asia-Pacific region is expected to show high growth for congestive heart failure devices market due to rise in geriatric population in India and China.

Request a Sample Brochure of the Report @ https://www.persistencemarketresearch.com/samples/12643

Some of the key players of congestive heart failure disease are Boston Scientific Corporation, Medtronic PLC, Abiomed, Inc., HeartWare International, Inc., Jarvik Heart, Inc., LivaNova PLC, ReliantHeart Inc.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Congestive Heart Failure (CHF) Treatment Devices Market Latest Trends by 2024 here

News-ID: 1010294 • Views: 233

More Releases from Persistence Market Research

Polycaprolactone Market Estimated To Experience A Hike In Growth By 2026
Polycaprolactone, a biodegradable polymer, is gaining widespread traction considering its value-adding properties including high flexibility, hydrophobic nature, molecular weight distribution, and low viscosity. Moreover, deepening production of thermoplastic Polyurethane, Polyurethane (PU), and Polyols would also contribute the increased consumption of polycaprolactone. Thermoplastic polyurethane would remain the largest category with close to 45% share of the polycaprolactone market. A study by Persistence Market Research projects the polycaprolactone market to exhibit a promising
Isostearyl Alcohol Market by Top Brands, Trends and Demand 2024
The chemical industry is focused to keep the business operations running along with ensuring the labor safety amid the COVID-19 pandemic. To recover the losses created by the decline in demand for various products, the companies are capitalizing on the escalating demand for products such as disinfectants and personal protective equipment. Many leading players in the chemical industry have expanded their business to enter into the production of safety products.
The Automatic Biopsy Systems market to stand in a good stead from 2019 to 2029
A biopsy is a method in which body tissue separated from any organ of the body for the diagnosis of disease. In some cases, the tissue is removed by using the simple needles and in some cases tissue removed by surgical methods. Automatic biopsy systems perform a highly accurate clinical intervention since most of the Automatic biopsy machines work under image guidance. Robotic automatic biopsy systems is the latest novel
Home Care Chemicals Market by Top Brands, Trends and Demand By 2020 End
The impact of COVID-19 pandemic can be felt across the chemical industry. The growing inability in the production and manufacturing processes, in the light of the self-quarantined workforce has caused a major disruption in the supply chain across the sector. Restrictions encouraged by this pandemic are obstructing the production of essentials such as life-saving drugs. Request For Report Sample@ https://www.persistencemarketresearch.com/samples/4528 The nature of operation in chemical plants that cannot be easily stopped

All 5 Releases


More Releases for CHF

Screening Eagle raises CHF 55 million to protect the built world
Screening Eagle Technologies (SET), a cloud-based technology platform connecting sensors, software, and data for intelligent inspection of assets and infrastructure, is pleased to announce it has raised CHF 55 million in its first institutional round of equity funding. Switzerland - April 3, 2020 -- Screening Eagle is on a mission to protect the built world. Massive economic value is at risk from aging global infrastructure and construction birth defects in
Global Congestive Heart Failure (CHF) Market Status, Analysis, Growth Factor, Ap …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Congestive Heart Failure (CHF) Market Research Report 2018” provides an in-depth analysis of the Congestive Heart Failure (CHF) with the forecast of market size and growth. The analysis includes addressable market, market by volume, and market share by business type and by segment (external and in-house).The research study examines the
Congestive Heart Failure (CHF) Treatment Devices Market: Report Scope and Market …
Congestive Heart Failure (CHF) is a chronic condition of a body, which adversely affects the pumping efficiency of the cardiac muscles and the heart. It occurs due to accretion of fluid around the heart that may contribute towards ineffective pumping of the heart. This condition may result in shortness of breathing, swelling and weakness. Left-sided CHF is the more commonly noted than right-sided CHF. Left-sided CHF occurs due to
Congestive Heart Failure (CHF) Treatment Devices Market Estimated to Flourish by …
Congestive Heart Failure (CHF) is a chronic condition of a body, which adversely affects the pumping efficiency of the cardiac muscles and the heart. It occurs due to accretion of fluid around the heart that may contribute towards ineffective pumping of the heart. This condition may result in shortness of breathing, swelling and weakness. Left-sided CHF is the more commonly noted than right-sided CHF. Left-sided CHF occurs due to malfunctioning
Congestive Heart Failure (CHF) Treatment Devices Market Estimated to Flourish by …
Congestive Heart Failure (CHF) is a chronic condition of a body, which adversely affects the pumping efficiency of the cardiac muscles and the heart. It occurs due to accretion of fluid around the heart that may contribute towards ineffective pumping of the heart. This condition may result in shortness of breathing, swelling and weakness. Left-sided CHF is the more commonly noted than right-sided CHF. Left-sided CHF occurs due to malfunctioning
Congestive Heart Failure (CHF) Treatment Devices Market Is Expected to Reach $14 …
Global Congestive Heart Failure (CHF) Treatment Devices Market would reach $14.8 billion by 2022, at a CAGR of 5.5% from 2016 to 2022, according to a new report published by Allied Market Research. Implantable cardioverter-defibrillator (ICDs) segment is expected to dominate the global CHF treatment devices market throughout the forecast period. North America is projected to continue its lead in terms of revenue, accounting for more than two-fifths share of